AnaptysBio, Inc. (ANAB)
63.15
+0.96
(+1.54%)
USD |
NASDAQ |
May 15, 16:00
63.22
+0.07
(+0.11%)
After-Hours: 20:00
AnaptysBio Total Liabilities (Quarterly) : 316.94M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | 152.76M |
| TG Therapeutics, Inc. | 945.71M |
| ADMA Biologics, Inc. | 274.86M |
| Mirum Pharmaceuticals, Inc. | 648.42M |
| Rocket Pharmaceuticals, Inc. | 47.37M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 329.68M |
| Shareholders Equity (Quarterly) | 12.75M |
| Debt to Equity Ratio | 21.76 |
| Current Ratio | 7.580 |
| Net Debt Paydown Yield | 1.72% |